Cover Image

Snowdon Inc. - 產品平台檢討

Snowdon Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 192828
出版日期 內容資訊 英文 22 Pages
Back to Top
Snowdon Inc. - 產品平台檢討 Snowdon Inc. - Product Pipeline Review - 2015
出版日期: 2015年06月30日 內容資訊: 英文 22 Pages



Snowdon Inc. 是致力於研發治療急性及慢性疼痛、傳染疾病、神經系統疾病的新小分子治療藥之製藥公司。該公司同時也提供疾病的早期發現計劃、神經系統疾病的新治療藥、將過多的麩胺酸鹽傳達降回正常值用的新治療法。

本報告提供Snowdon Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Snowdon Inc.的基本資料

Snowdon Inc.概要

  • 主要資訊
  • 企業資料

Snowdon Inc.:R&D概要

  • 主要的治療範圍

Snowdon Inc.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Snowdon Inc.:開發中產品概況

  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Snowdon Inc.:藥物簡介

  • Small Molecules for Neurological Disorders
  • SND-121
  • SND-159
  • SND-226
  • SNT-18

Snowdon Inc.:開發中產品

  • 各分子類型

Snowdon Inc.:暫停中的計劃

Snowdon Inc.:總公司和子公司的所在地



Product Code: GMDHC07222CDB


Global Markets Direct's, 'Snowdon Inc. - Product Pipeline Review - 2015', provides an overview of the Snowdon Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Snowdon Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


  • The report provides brief overview of Snowdon Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Snowdon Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Snowdon Inc.'s pipeline products

Reasons to buy

  • Evaluate Snowdon Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Snowdon Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Snowdon Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Snowdon Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Snowdon Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Snowdon Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Snowdon Inc. Snapshot
    • Snowdon Inc. Overview
    • Key Information
    • Key Facts
  • Snowdon Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Snowdon Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Snowdon Inc. - Pipeline Products Glance
    • Snowdon Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Snowdon Inc. - Drug Profiles
    • Small Molecules for Neurological Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SND-121
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SND-121 Prodrug
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SNT-18
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SND-159
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SND-226
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Snowdon Inc. - Pipeline Analysis
  • Snowdon Inc. - Pipeline Products by Molecule Type
  • Snowdon Inc. - Dormant Projects
  • Snowdon Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Snowdon Inc., Key Information
  • Snowdon Inc., Key Facts
  • Snowdon Inc. - Pipeline by Indication, 2015
  • Snowdon Inc. - Pipeline by Stage of Development, 2015
  • Snowdon Inc. - Monotherapy Products in Pipeline, 2015
  • Snowdon Inc. - Preclinical, 2015
  • Snowdon Inc. - Discovery, 2015
  • Snowdon Inc. - Pipeline by Molecule Type, 2015
  • Snowdon Inc. - Dormant Developmental Projects,2015

List of Figures

  • Snowdon Inc. - Pipeline by Top 10 Indication, 2015
  • Snowdon Inc. - Pipeline by Stage of Development, 2015
  • Snowdon Inc. - Monotherapy Products in Pipeline, 2015
  • Snowdon Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top